Header Logo

Michael Jackson, PhD, MPH

TitleSenior Investigator
InstitutionKaiser Permanente Washington
DepartmentKaiser Permanente Washington Health Research Institute
Address1730 Minor Ave
Seattle WA 98101
ORCID ORCID Icon0000-0002-2340-0256 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Michael L. Jackson, PhD, MPH’s research focuses on understanding how infectious diseases spread, and on designing and evaluating interventions such as vaccination programs. Dr. Jackson is the Kaiser Permanente Washington Health Research Institute (KPWHRI) principal investigator for the United States Influenza Vaccine Effectiveness Network. This Network aims to provide ongoing evaluations of the U.S. influenza vaccination program. Dr. Jackson uses data from this Network to study influenza vaccine effectiveness, to estimate the burden of disease caused by influenza, and to advance the methodology of vaccine effectiveness studies. He also uses mathematical models to predict the impact of vaccination programs on the spread of infectious diseases such as Haemophilus influenza type b (Hib) and Neisseria meningitidis.

    Dr. Jackson is a co-investigator on the Vaccine Safety Datalink (VSD) Project. The VSD, a collaboration among nine U.S. managed care organizations and the Centers for Disease Control and Prevention (CDC), is the world’s premier system for post-licensure studies of vaccine safety. As a VSD co-investigator, Dr. Jackson leads studies of the safety of childhood immunizations and develops methods for using managed care data for vaccine safety studies.

    While studying for his PhD at the University of Washington, Dr. Jackson was a graduate research associate with KPWHRI from 2002 to 2007, and then a postdoctoral fellow at KPWHRI from 2007 to 2008. He then spent two years as an Epidemic Intelligence Service (EIS) officer with the CDC in Atlanta. As an EIS officer, Dr. Jackson helped lead investigations of whooping cough outbreaks and of the 2009 influenza pandemic. He also designed and oversaw an enhanced surveillance system for invasive Hib disease in the U.S. during the 2008–2009 shortage of Hib vaccines. He returned to KPWHRI as an assistant investigator in 2010.

    Collapse Research 
    Collapse research activities and funding
    R01AI132362     (JACKSON, MICHAEL L.)Aug 1, 2017 - Jul 31, 2021
    NIH/NIAID
    Forecasting influenza epidemics using a mechanistic epidemic model
    Role: Principal Investigator

    U01IP001037     (JACKSON, MICHAEL L.)Aug 1, 2016 - Jul 31, 2021
    CDC/NCIRD
    Prospective annual estimates of influenza vaccine effectiveness and burden of disease
    Role: Principal Investigator

    U01IP000466     (JACKSON, MICHAEL L.)Jul 1, 2011 - Jun 30, 2016
    CDC/NCIRD
    Core_Prospective population-based estimation of influenza vaccine effectiveness a
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Daley MF, Reifler LM, Shoup JA, Narwaney KJ, Kharbanda EO, Groom HC, Jackson ML, Jacobsen SJ, McLean HQ, Klein NP, Williams JTB, Weintraub ES, McNeil MM, Glanz JM. Temporal Trends in Undervaccination: A Population-Based Cohort Study. Am J Prev Med. 2021 07; 61(1):64-72. PMID: 34148627.
      Citations:    
    2. Jackson ML, Hart GR, McCulloch DJ, Adler A, Brandstetter E, Fay K, Han P, Lacombe K, Lee J, Sibley TR, Nickerson DA, Rieder MJ, Starita L, Englund JA, Bedford T, Chu H, Famulare M, Seattle Flu Study Investigators. Effects of weather-related social distancing on city-scale transmission of respiratory viruses: a retrospective cohort study. BMC Infect Dis. 2021 Apr 09; 21(1):335. PMID: 33836685; PMCID: PMC8033554.
      Citations:    
    3. Jackson ML, Ferdinands J, Nowalk MP, Zimmerman RK, Kieke B, Gaglani M, Murthy K, Petrie JG, Martin ET, Chung JR, Flannery B, Jackson LA. Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study. BMC Public Health. 2021 03 16; 21(1):516. PMID: 33726743; PMCID: PMC7968177.
      Citations:    
    4. Jackson ML, Starita L, Kiniry E, Phillips CH, Wellwood S, Cho S, Kiavand A, Truong M, Han P, Richardson M, Wolf CR, Heimonen J, Nickerson DA, Chu HY. Incidence of medically attended acute respiratory illnesses due to respiratory viruses across the life course during the 2018/19 influenza season. Clin Infect Dis. 2021 Feb 16. PMID: 33590002; PMCID: PMC7929037.
      Citations:    
    5. Jackson ML, Scott E, Kuypers J, Nalla AK, Roychoudury P, Chu HY. Epidemiology of Respiratory Syncytial Virus Across Five Influenza Seasons Among Adults and Children One Year of Age and Older-Washington State, 2011/2012-2015/2016. J Infect Dis. 2021 01 04; 223(1):147-156. PMID: 32556287.
      Citations:    
    6. Greene DN, Jackson ML, Hillyard DR, Delgado JC, Schmidt RL. Decreasing median age of COVID-19 cases in the United States-Changing epidemiology or changing surveillance? PLoS One. 2020; 15(10):e0240783. PMID: 33057403; PMCID: PMC7561139.
      Citations:    
    7. Jackson ML. Low-impact social distancing interventions to mitigate local epidemics of SARS-CoV-2. Microbes Infect. 2020 Nov - Dec; 22(10):611-616. PMID: 32977019; PMCID: PMC7508051.
      Citations:    
    8. Chubak J, Anderson ML, Cook AJ, Murphy CC, Jackson ML, Green BB. Methodologic Considerations in Calculating and Analyzing Proportion of Time Covered as a Measure of Longitudinal Cancer Screening Adherence. Cancer Epidemiol Biomarkers Prev. 2020 08; 29(8):1549-1556. PMID: 32467346; PMCID: PMC7415680.
      Citations:    
    9. Weinmann S, Irving SA, Koppolu P, Naleway AL, Belongia EA, Hambidge SJ, Jackson ML, Klein NP, Lewin B, Liles E, Marin M, Smith N, Weintraub E, Chun C. Incidence of herpes zoster among varicella-vaccinated children, by number of vaccine doses and simultaneous administration of measles, mumps, and rubella vaccine. Vaccine. 2020 08 18; 38(37):5880-5884. PMID: 32444193.
      Citations:    
    10. Newcomer SR, Daley MF, Narwaney KJ, Xu S, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McLean HQ, Nordin JD, Zerbo O, Glanz JM. Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age. Pediatr Infect Dis J. 2020 03; 39(3):247-253. PMID: 32032310.
      Citations:    
    11. Weinmann S, Naleway AL, Koppolu P, Baxter R, Belongia EA, Hambidge SJ, Irving SA, Jackson ML, Klein NP, Lewin B, Liles E, Marin M, Smith N, Weintraub E, Chun C. Incidence of Herpes Zoster Among Children: 2003-2014. Pediatrics. 2019 07; 144(1). PMID: 31182552; PMCID: PMC7748320.
      Citations:    
    12. Naleway AL, Ball S, Kwong JC, Wyant BE, Katz MA, Regan AK, Russell ML, Klein NP, Chung H, Simmonds KA, Azziz-Baumgartner E, Feldman BS, Levy A, Fell DB, Drews SJ, Garg S, Effler P, Barda N, Irving SA, Shifflett P, Jackson ML, Thompson MG. Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy: Multicountry Protocol for a Retrospective Cohort Study. JMIR Res Protoc. 2019 Jan 21; 8(1):e11333. PMID: 30664495.
      Citations:    
    13. Jackson ML. Use of self-reported vaccination status can bias vaccine effectiveness estimates from test-negative studies. Vaccine X. 2019 Apr 11; 1:100003. PMID: 33826685; PMCID: PMC6668222.
      Citations:    
    14. Jackson ML, Diallo AO, Médah I, Bicaba BW, Yaméogo I, Koussoubé D, Ouédraogo R, Sangaré L, Mbaeyi SA. Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt. PLoS One. 2018; 13(10):e0206117. PMID: 30359419.
      Citations:    
    15. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Sheth SS, Zhu J, Naleway AL, Klein NP, Hechter R, Daley MF, Donahue JG, Jackson ML, Kawai AT, Sukumaran L, Nordin JD. Risk of Spontaneous Abortion After Inadvertent Human Papillomavirus Vaccination in Pregnancy. Obstet Gynecol. 2018 Jul; 132(1):35-44. PMID: 29889760.
      Citations:    
    16. Jackson ML, Yu O, Nelson JC, Nordin JD, Tartof SY, Klein NP, Donahue JG, Irving SA, Glanz JM, McNeil MM, Jackson LA. Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. Pharmacoepidemiol Drug Saf. 2018 Aug; 27(8):921-925. PMID: 29862604.
      Citations:    
    17. Daley MF, Shoup JA, Newcomer SR, Jackson ML, Groom HC, Jacobsen SJ, McLean HQ, Klein NP, Weintraub ES, McNeil MM, Glanz JM. Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule. Acad Pediatr. 2018 Sep - Oct; 18(7):754-762. PMID: 29604461.
      Citations:    
    18. Glanz JM, Newcomer SR, Daley MF, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McCarthy NL, McClure DL, Narwaney KJ, Nordin JD, Zerbo O. Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age. JAMA. 2018 03 06; 319(9):906-913. PMID: 29509866.
      Citations:    
    19. Jackson ML, Phillips CH, Benoit J, Kiniry E, Madziwa L, Nelson JC, Jackson LA. The impact of selection bias on vaccine effectiveness estimates from test-negative studies. Vaccine. 2018 01 29; 36(5):751-757. PMID: 29254838.
      Citations:    
    20. Jackson ML, Phillips CH, Benoit J, Jackson LA, Gaglani M, Murthy K, McLean HQ, Belongia EA, Malosh R, Zimmerman R, Flannery B. Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons. Vaccine. 2018 01 25; 36(4):467-472. PMID: 29249545.
      Citations:    
    21. Daley MF, Clarke CL, Glanz JM, Xu S, Hambidge SJ, Donahue JG, Nordin JD, Klein NP, Jacobsen SJ, Naleway AL, Jackson ML, Lee G, Duffy J, Weintraub E. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf. 2018 Jan; 27(1):59-68. PMID: 29148124.
      Citations:    
    22. Lipkind HS, Vazquez-Benitez G, Nordin JD, Romitti PA, Naleway AL, Klein NP, Hechter RC, Jackson ML, Hambidge SJ, Lee GM, Sukumaran L, Kharbanda EO. Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy. Obstet Gynecol. 2017 09; 130(3):599-608. PMID: 28796684.
      Citations:    
    23. Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B. Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season. N Engl J Med. 2017 08 10; 377(6):534-543. PMID: 28792867.
      Citations:    
    24. Chung JR, Flannery B, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Petrie JG, Martin ET, Monto AS, McLean HQ, Belongia EA, Gaglani M, Fry AM. Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States. J Infect Dis. 2017 07 15; 216(2):284-285. PMID: 28633308.
      Citations:    
    25. Daley MF, Glanz JM, Newcomer SR, Jackson ML, Groom HC, Lugg MM, McLean HQ, Klein NP, Weintraub ES, McNeil MM. Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule. Vaccine. 2017 04 04; 35(15):1873-1878. PMID: 28285983.
      Citations:    
    26. Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Foust A, Sessions W, Berman L, Spencer S, Fry AM. Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. MMWR Morb Mortal Wkly Rep. 2017 Feb 17; 66(6):167-171. PMID: 28207689.
      Citations:    
    27. Jackson ML, Walker R, Lee S, Larson E, Dublin S. Reply to: Quality Indicators of Drug Use and Risk of Pneumonia in Older Adults without Dementia. J Am Geriatr Soc. 2017 06; 65(6):1365-1366. PMID: 28170082.
      Citations:    
    28. Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Murthy K, Fry AM, Flannery B. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. Clin Infect Dis. 2016 Dec 15; 63(12):1564-1573. PMID: 27702768.
      Citations:    
    29. Jackson MA, Blackburn JA, Price NP, Vermillion KE, Peterson SC, Ferrence GM. A one-pot synthesis of 1,6,9,13-tetraoxadispiro(4.2.4.2)tetradecane by hydrodeoxygenation of xylose using a palladium catalyst. Carbohydr Res. 2016 Sep 02; 432:9-16. PMID: 27341396.
      Citations:    
    30. Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, DeStefano F, Daley MF. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink. Vaccine. 2016 Feb 15; 34 Suppl 1:A1-A29. PMID: 26830300.
      Citations:    
    31. Sukumaran L, McCarthy NL, Kharbanda EO, Weintraub ES, Vazquez-Benitez G, McNeil MM, Li R, Klein NP, Hambidge SJ, Naleway AL, Lugg MM, Jackson ML, King JP, DeStefano F, Omer SB, Orenstein WA. Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy. Obstet Gynecol. 2015 Nov; 126(5):1069-74. PMID: 26444109.
      Citations:    
    32. Glanz JM, Newcomer SR, Daley MF, McClure DL, Baxter RP, Jackson ML, Naleway AL, Lugg MM, DeStefano F. Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children. Vaccine. 2015 Nov 27; 33(48):6736-44. PMID: 26518400.
      Citations:    
    33. Jackson ML, Jackson LA, Kieke B, McClure D, Gaglani M, Murthy K, Malosh R, Monto A, Zimmerman RK, Foppa IM, Flannery B, Thompson MG. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons. Vaccine. 2015 Sep 22; 33(39):5181-7. PMID: 26271827.
      Citations:    
    34. Jackson ML, Rothman KJ. Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness. Vaccine. 2015 Mar 10; 33(11):1313-6. PMID: 25659280.
      Citations:    
    35. Jackson ML. Influenza vaccine effectiveness in elderly people. Lancet Infect Dis. 2014 Dec; 14(12):1169-70. PMID: 25455972.
      Citations:    
    36. Jackson ML, Henrikson NB, Grossman DC. Evaluating Washington State's immunization information system as a research tool. Acad Pediatr. 2014 Jan-Feb; 14(1):71-6. PMID: 24369871.
      Citations:    
    37. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine. 2013 Apr 19; 31(17):2165-8. PMID: 23499601.
      Citations:    
    38. Jackson ML. Challenges in comparing the safety of different vaccination schedules. Vaccine. 2013 Apr 19; 31(17):2126-9. PMID: 23470238.
      Citations:    
    39. Jackson ML, Rose CE, Cohn A, Coronado F, Clark TA, Wenger JD, Bulkow L, Bruce MG, Messonnier NE, Hennessy TW. Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs. Emerg Infect Dis. 2012 Jan; 18(1):13-20. PMID: 22257582.
      Citations:    
    40. Jackson ML, France AM, Hancock K, Lu X, Veguilla V, Sun H, Liu F, Hadler J, Harcourt BH, Esposito DH, Zimmerman CM, Katz JM, Fry AM, Schrag SJ. Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009. Clin Infect Dis. 2011 Sep; 53(5):455-62. PMID: 21844028.
      Citations:    
    41. Jackson ML, Nelson JC, Jackson LA. Why do covariates defined by International Classification of Diseases codes fail to remove confounding in pharmacoepidemiologic studies among seniors? Pharmacoepidemiol Drug Saf. 2011 Aug; 20(8):858-65. PMID: 21671442.
      Citations:    
    42. Jackson ML, Nelson JC, Jackson LA. Risk factors for community-acquired pneumonia in immunocompetent seniors. J Am Geriatr Soc. 2009 May; 57(5):882-8. PMID: 19453307.
      Citations:    
    43. Jackson ML, Nelson JC, Chen RT, Davis RL, Jackson LA. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study. Pharmacoepidemiol Drug Saf. 2007 Jul; 16(7):790-6. PMID: 17286320.
      Citations:    
    44. Guzman A, Rohan KJ, Yousufi SM, Nguyen MC, Jackson MA, Soriano JJ, Postolache TT. Mood sensitivity to seasonal changes in African college students living in the greater Washington D.C. metropolitan area. ScientificWorldJournal. 2007 May 01; 7:584-91. PMID: 17525823; PMCID: PMC5901367.
      Citations:    
    45. Guzman A, Tonelli LH, Roberts D, Stiller JW, Jackson MA, Soriano JJ, Yousufi S, Rohan KJ, Komarow H, Postolache TT. Mood-worsening with high-pollen-counts and seasonality: a preliminary report. J Affect Disord. 2007 Aug; 101(1-3):269-74. PMID: 17222915; PMCID: PMC1949487.
      Citations:    
    46. Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, Jackson LA. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004 Dec 01; 39(11):1642-50. PMID: 15578365.
      Citations:    
    47. Agumadu CO, Yousufi SM, Malik IS, Nguyen MC, Jackson MA, Soleymani K, Thrower CM, Peterman MJ, Walters GW, Niemtzoff MJ, Bartko JJ, Postolache TT. Seasonal variation in mood in African American college students in the Washington, D.C., metropolitan area. Am J Psychiatry. 2004 Jun; 161(6):1084-9. PMID: 15169697.
      Citations:    
    48. Hall FT, O'Brien CJ, Clifford AR, McNeil EB, Bron L, Jackson MA. Clinical outcome following total laryngectomy for cancer. ANZ J Surg. 2003 May; 73(5):300-5. PMID: 12752286.
      Citations:    
    49. Aeschbach D, Sher L, Postolache TT, Matthews JR, Jackson MA, Wehr TA. A longer biological night in long sleepers than in short sleepers. J Clin Endocrinol Metab. 2003 Jan; 88(1):26-30. PMID: 12519823.
      Citations:    
    Concepts (216)
    Explore
    _
    Co-Authors (17)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _
    -->

    © 2021 Kaiser Permanente

    KP Researcher Profiles is made possible with the support of the Kaiser Permanente Research.